Cash Flow from Investing Activities (Annual)

Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.

ACADIA Pharmaceuticals Inc. (ACAD) had Cash Flow from Investing Activities of $-30.54M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$957.80M
Net Income	$226.45M
Cost of Goods Sold	$81.84M
Gross Profit	$875.96M
Operating Expenses	$727.00M
Operating Income	$230.79M
Non-Operating Income/Expense	$27.28M
Pre-Tax Income	$258.07M
Normalized Pre-Tax Income	$258.07M
Income after Taxes	$226.45M
Income from Continuous Operations	$226.45M
Consolidated Net Income/Loss	$226.45M
Normalized Income after Taxes	$226.45M
EBIT	$230.79M
EBITDA	$237.37M
Weighted-Average Shares Outstanding (Basic)	165.72M
Weighted-Average Shares Outstanding (Diluted)	166.36M
Earnings per Share (EPS) (Basic)	$1.37
Earnings per Share (EPS) (Diluted)	$1.36
Balance Sheet Financials
Current Assets	$938.32M
Property, Plant, and Equipment	$4.21M
Long-Term Assets	$249.44M
Total Assets	$1.19B
Current Liabilities	$394.87M
Long-Term Debt	--
Long-Term Liabilities	$60.09M
Total Liabilities	$454.96M
Common Equity	$732.79M
Tangible Shareholders Equity	$613.01M
Shareholders Equity	$732.79M
Common Shares Outstanding	166.71M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$157.72M
Cash Flow from Investing Activities	$-30.54M
Cash Flow from Financial Activities	$6.84M
Beginning Cash	$194.43M
End Cash	$328.36M
Increase/Decrease in Cash	$133.93M
Stock-Based Compensation	$67.05M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.38
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	--
Debt to Equity Ratio	--
Gross Margin	91.46%
Operating Margin	24.10%
EBIT Margin	24.10%
EBITDA Margin	24.78%
Pre-Tax Profit Margin	26.94%
Profit Margin	23.64%
Free Cash Flow	$157.20M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.81
Inventory Turnover	3.73
Receiveable Turnover	9.15
Days Sales in Receivables	39.90
Return on Equity	30.90%
Return on Tangible Equity	36.94%
Return on Assets	19.07%
Return on Investments	30.90%
Book Value Per Share	$4.40
Free Cash Flow per Share	$0.94
Operating Cash Flow per Share	$0.95

Data from Zacks Investment Research, Inc.